La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Demant Résultats passés
Passé contrôle des critères 2/6
Demant a connu une croissance annuelle moyenne de ses bénéfices de 15.5%, tandis que le secteur Medical Equipment a vu ses bénéfices augmenter de en hausse à 10.4% par an. Les revenus ont augmenté de en hausse à un taux moyen de 10.9% par an. Le rendement des capitaux propres de Demant est 26.7% et ses marges nettes sont de 11.1%.
Informations clés
15.5%
Taux de croissance des bénéfices
17.6%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | -1.7% |
Taux de croissance des recettes | 10.9% |
Rendement des fonds propres | 26.7% |
Marge nette | 11.1% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Is There An Opportunity With Demant A/S' (CPH:DEMANT) 42% Undervaluation?
Sep 12Is Demant (CPH:DEMANT) Using Too Much Debt?
Aug 30Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Jul 14Here's Why We Think Demant (CPH:DEMANT) Might Deserve Your Attention Today
Jun 30At kr.326, Is It Time To Put Demant A/S (CPH:DEMANT) On Your Watch List?
Jun 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 97% Above Its Share Price
Jun 03We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
May 22Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)
Apr 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Mar 18Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal
Mar 06Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching
Feb 22Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet
Feb 08Demant A/S (CPH:DEMANT) Not Flying Under The Radar
Jan 22A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jan 04At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?
Dec 17Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital
Oct 31Is Demant (CPH:DEMANT) Using Too Much Debt?
Oct 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price
Oct 01Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital
Jul 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Jul 11A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jun 26Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly
Jun 13Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Apr 18Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?
Apr 04Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?
Mar 21These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well
Mar 08Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price
Dec 06Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Nov 22We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
Oct 04Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?
Sep 20Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price
Sep 07What Is Demant A/S's (CPH:DEMANT) Share Price Doing?
Aug 19Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital
Jul 18Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly
Jun 22Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jun 09If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late
May 28Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?
May 16Shareholders Are Optimistic That Demant (CPH:DEMANT) Will Multiply In Value
Apr 09Is Demant (CPH:DEMANT) A Risky Investment?
Mar 16Shareholders Would Not Be Objecting To Demant A/S' (CPH:DEMANT) CEO Compensation And Here's Why
Mar 03Is There An Opportunity With Demant A/S' (CPH:DEMANT) 23% Undervaluation?
Mar 01Should You Be Adding Demant (CPH:DEMANT) To Your Watchlist Today?
Feb 17What Does Demant A/S's (CPH:DEMANT) Share Price Indicate?
Feb 05Capital Investment Trends At Demant (CPH:DEMANT) Look Strong
Jan 05Does Demant (CPH:DEMANT) Have A Healthy Balance Sheet?
Dec 08Estimating The Fair Value Of Demant A/S (CPH:DEMANT)
Nov 13Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Oct 31Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Oct 04These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Safely
Sep 08Is It Time To Consider Buying Demant A/S (CPH:DEMANT)?
Jul 26Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return
Jun 27Is Demant (CPH:DEMANT) Using Too Much Debt?
May 31Ventilation des recettes et des dépenses
Comment Demant gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 22,836 | 2,535 | 11,490 | 1,536 |
31 Mar 24 | 22,640 | 2,544 | 11,263 | 1,473 |
31 Dec 23 | 22,443 | 2,552 | 11,036 | 1,410 |
30 Sep 23 | 21,442 | 2,577 | 10,732 | 1,291 |
30 Jun 23 | 20,902 | 2,488 | 10,633 | 1,270 |
31 Mar 23 | 20,304 | 2,381 | 10,440 | 1,292 |
31 Dec 22 | 19,705 | 2,274 | 10,246 | 1,314 |
30 Sep 22 | 19,181 | 2,460 | 9,851 | 1,274 |
30 Jun 22 | 18,656 | 2,645 | 9,455 | 1,233 |
31 Mar 22 | 18,281 | 2,671 | 9,178 | 1,186 |
31 Dec 21 | 17,905 | 2,696 | 8,900 | 1,139 |
30 Sep 21 | 17,521 | 2,453 | 8,651 | 1,170 |
30 Jun 21 | 17,137 | 2,209 | 8,401 | 1,200 |
31 Mar 21 | 15,803 | 1,665 | 8,145 | 1,231 |
31 Dec 20 | 14,469 | 1,121 | 7,889 | 1,261 |
30 Sep 20 | 14,072 | 970 | 7,952 | 1,224 |
30 Jun 20 | 13,674 | 818 | 8,014 | 1,186 |
31 Mar 20 | 14,310 | 1,140 | 8,138 | 1,153 |
31 Dec 19 | 14,946 | 1,462 | 8,261 | 1,120 |
30 Sep 19 | 14,728 | 1,579 | 8,068 | 1,093 |
30 Jun 19 | 14,510 | 1,695 | 7,874 | 1,066 |
31 Mar 19 | 14,224 | 1,759 | 7,593 | 1,030 |
31 Dec 18 | 13,937 | 1,823 | 7,312 | 994 |
30 Sep 18 | 13,699 | 1,836 | 7,084 | 956 |
30 Jun 18 | 13,461 | 1,849 | 6,856 | 918 |
31 Mar 18 | 13,325 | 1,802 | 6,809 | 887 |
31 Dec 17 | 13,189 | 1,754 | 6,762 | 856 |
30 Sep 17 | 12,943 | 1,689 | 6,680 | 831 |
30 Jun 17 | 12,697 | 1,624 | 6,597 | 806 |
31 Mar 17 | 12,350 | 1,542 | 6,436 | 795 |
31 Dec 16 | 12,002 | 1,459 | 6,275 | 784 |
30 Sep 16 | 11,717 | 1,429 | 6,068 | 787 |
30 Jun 16 | 11,432 | 1,399 | 5,860 | 790 |
31 Mar 16 | 11,049 | 1,418 | 5,573 | 777 |
31 Dec 15 | 10,665 | 1,436 | 5,285 | 763 |
30 Sep 15 | 10,258 | 1,402 | 5,090 | 731 |
30 Jun 15 | 9,850 | 1,367 | 4,894 | 699 |
31 Mar 15 | 9,598 | 1,347 | 4,693 | 690 |
31 Dec 14 | 9,346 | 1,326 | 4,491 | 680 |
30 Sep 14 | 9,221 | 1,301 | 4,420 | 673 |
30 Jun 14 | 9,095 | 1,275 | 4,348 | 665 |
31 Mar 14 | 9,027 | 1,280 | 4,294 | 650 |
31 Dec 13 | 8,959 | 1,285 | 4,239 | 634 |
Des revenus de qualité: DEMANT a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de DEMANT (11.1%) sont inférieures à celles de l'année dernière (11.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de DEMANT ont augmenté de 15.5% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de DEMANT au cours de l'année écoulée ( 1.9% ) est inférieure à sa moyenne sur 5 ans ( 15.5% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices DEMANT au cours de l'année écoulée ( 1.9% ) n'a pas surpassé celle du secteur Medical Equipment 20%.
Rendement des fonds propres
ROE élevé: Bien que le retour sur capitaux propres ( 26.65% ) de DEMANT soit élevé, cette mesure est faussée en raison de son niveau d'endettement élevé.